21 CFR 314.70 - Supplements and Other Changes to an Approved Application

What it says

Changes to an approved application, including manufacturing process, facility, equipment or specification changes, must be reported to FDA through one of several categories, prior approval supplement, changes being effected supplement, or annual report, depending on the change's potential to affect product identity, strength, quality, purity or potency.

Paraphrased for plain-language clarity. Always verify against the current published regulation text.

What it means in practice

• This regulation provides the specific US regulatory mechanism implementing the change management principles described more conceptually in ICH Q12, translating Established Conditions and change classification into concrete FDA reporting category requirements.
• Correctly classifying a change into the right reporting category, prior approval, changes being effected, or annual report, is itself an important regulatory judgment, since misclassifying a change as lower-risk than it actually is can result in implementing a change without required prior FDA approval.
• The reporting category required often depends on which specific element of the approved application the change touches, connecting directly to the Established Conditions concept from ICH Q12 discussed earlier in this library.

What FDA inspectors look for

• Whether manufacturing, facility or process changes implemented at a site were correctly classified and reported through the appropriate supplement or annual report category.
• Whether prior approval supplements requiring FDA approval before implementation were genuinely not implemented until that approval was actually obtained.
• Whether the site's change control system correctly identifies when a proposed change triggers a regulatory reporting obligation, not just an internal quality assessment.

Related regulations